Neurosteroid Binding Sites on the GABAA Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence
Despite the prevalence of alcohol abuse and dependence in the US and Europe, there are only five approved pharmacotherapies for alcohol dependence. Moreover, these pharmacotherapeutic options have limited clinical utility. The purpose of this paper is to present pertinent literature suggesting that...
Saved in:
Main Authors: | Mary W. Hulin, Russell J. Amato, Johnny R. Porter, Catalin M. Filipeanu, Peter J. Winsauer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Advances in Pharmacological Sciences |
Online Access: | http://dx.doi.org/10.1155/2011/926361 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Augmentation of Tonic GABAA Inhibition in Absence Epilepsy: Therapeutic Value of Inverse Agonists at Extrasynaptic GABAA Receptors
by: Adam C. Errington, et al.
Published: (2011-01-01) -
Treatment of Postpartum Depression with Neurosteroids
by: Reda Stankevičiūtė, et al.
Published: (2024-03-01) -
GABA𝐀 Receptor Subtypes: Novel Targets for Novel Medicines
by: Naheed R. Mirza, et al.
Published: (2012-01-01) -
Modulatory Effects of Eschscholzia californica Alkaloids on Recombinant GABAA Receptors
by: Milan Fedurco, et al.
Published: (2015-01-01) -
Tumor Necrosis Factor Alpha Mediates GABAA Receptor Trafficking to the Plasma Membrane of Spinal Cord Neurons In Vivo
by: Ellen D. Stück, et al.
Published: (2012-01-01)